Eric Alejandro Sweet-Cordero

Bio:   I completed by undergraduate studies at Stanford (BA-Anthropology, BS-Biology)., followed by medical school and pediatric residency at UCSF. I then completed clinical training in pediatric oncology at the Dana Farber Cancer Institute and Boston Children's Hospital, followed by a research post-doctoral fellowship under the mentorship of Tyler Jacks at MIT. I have been on the Stanford faculty since 2005. I run a research lab focused on cancer biology with disease interests in pediatric sarcomas and lung cancer. I am a physician-scientist and I attend on the oncology service at Packard Children's Hospital.

Professional Education

  • Fellowship: Dana Farber Cancer Institute Hematology Oncology Fellowship (2002) MA
  • Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (2002)
  • Residency: Univ of California San Francisco (1998) CA
  • Internship: Univ of California San Francisco (1996) CA
  • Medical Education: UCSF School of Medicine (1995) CA
  • B.A., Stanford University, Anthropology (1989)
  • B.S., Stanford University, Biology (1989)
  • MD, UC San Francisco, Medicine (1995)
  • Residency, UC San Francisco, Pediatrics (1998)
  • Fellowship, Boston Children's/Dana Farber, Hematology and Oncology (2002)

Honors & Awards

  • Sidney Kimmel Scholar, Sidney Kimmel Foundation (2006-2008)
  • Clinical Scientist Development Award, Doris Duke Foundation (2007-2010)
  • Scholar Award, Rita Allen Foundation (2008-2011)
  • member, American Society for Clinical Investigation (2010)
  • Innovative Research Award, SU2C (6/2011-6/2014)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.